Home Compare BN.PA vs FME.DE
Stock Comparison · Comparison

Danone vs Fresenius Medical Care: Which Stock Looks Stronger in 2026?

Fresenius Medical Care holds the cleaner structural position, with the lead spread across growth and valuation. Danone does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, but valuation adds another real layer to the result. The overall score gap is 21 points in favour of Fresenius Medical Care AG.

Trajectory Similarity
0.74
Similar
Peer-set rank: #28
within Danone S.A.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The match is driven mainly by margin consistency and investment intensity.

Similarity drivers
margin consistencyinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BN.PA
Danone S.A.
42
Peer-Score
Signal qualityHigh
vs
FME.DE
Fresenius Medical Care AG
63
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: BN.PA vs FME.DE Profitability 27 39 Stability 60 56 Valuation 52 86 Growth 33 71 BN.PA FME.DE
Gap Ranking
#1 Growth +38
#2 Valuation +34
#3 Profitability +12
#4 Stability +4
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BN.PA and FME.DE Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BN.PAFME.DE Relative valuation Structural strength

Fresenius Medical Care AG looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Fresenius Medical Care AG ranks near the top of the group on growth; Danone S.A. sits in the weaker half.
Valuation
On valuation, the edge is clear — both rank well, but Fresenius Medical Care AG sits noticeably higher.
Growth — Dominant Gap
BN.PA
33
FME.DE
71
Gap+38in favour of FME.DE

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Stability is the one area where Danone S.A. still pushes back materially — it is the steadier name on this dimension, which keeps the result from reading as one-way.

What this means for the comparison

The lead is built on both growth and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BN.PA vs FME.DE comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how BN.PA and FME.DE each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.